NCT00112866: Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme |
|
|
| Terminated | 2 | 30 | US | cilengitide, EMD 121974, therapeutic conventional surgery, pharmacological study, pharmacological studies, laboratory biomarker analysis | National Cancer Institute (NCI) | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor | 12/08 | 03/09 | | |
NCT00085254: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
|
| Completed | 2 | 112 | US | cilengitide, EMD 121974, temozolomide, SCH 52365, Temodal, Temodar, TMZ, radiation therapy, irradiation, radiotherapy, therapy, radiation, laboratory biomarker analysis, pharmacological study, pharmacological studies | National Cancer Institute (NCI) | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma | 11/12 | 11/12 | | |
